AA

Amal Amina Akberali Padiyath

Active Director Director DIN 09326606
DIN 09326606 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Amal Amina Akberali Padiyath

Data last updated:

Amal Amina Akberali Padiyath is a Director at Arkgen Pharma Private Limited (since 2021). The company operates in Pharma. Arkgen Pharma Private Limited reported revenue of ₹16.92 Cr (FY 2025).

DIN 09326606
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2021
Oldest Company Age 12 yrs
Largest company Arkgen Pharma Private Limited · ₹16.92 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arkgen Pharma Private Limited U74900KA2014PTC075574
Director26 Aug 20212014₹16.92 Cr (FY 2025)Active

Board colleagues of Amal Amina Akberali Padiyath

Directorship timeline

Open interactive timeline →
Arkgen Pharma Private Limited
Premium access

Shareholding and investment profile for Amal Amina Akberali Padiyath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amal Amina Akberali Padiyath

Amal Amina Akberali Padiyath currently holds 1 directorship: Arkgen Pharma Private Limited (Director, since 26 Aug 2021, revenue ₹16.92 Cr (FY 2025)).

Amal Amina Akberali Padiyath was first appointed on 26 Aug 2021 as Director at Arkgen Pharma Private Limited.

The current boards of Amal Amina Akberali Padiyath's companies include Hathika Akbarali (Arkgen Pharma Private Limited), Padiyath Mohammed Akbarali (Arkgen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available